台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    41.70
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    246
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
生華科 (6492)籌碼相關-華南永昌-豐原 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-豐原 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/14341.1500.0041.6031791.67%
2024/04/22140.5500.0040.6511870.53%
2024/04/19641.0800.0040.7061863.22%
2024/04/18541.9500.0041.9051822.74%
2024/04/16341.2000.0041.2531841.63%
2024/04/15242.3800.0042.3021871.06%
2024/03/20341.4700.0041.5531981.51%
2024/03/18142.3000.0042.2511990.50%
2024/03/08242.4000.0042.4022630.76%
2024/03/07242.7000.0043.5523220.62%
2024/03/06343.7000.0043.4033310.90%
2024/03/04843.7600.0043.6083392.36%
2024/03/01544.5300.0044.2553441.45%
2024/02/29144.9500.0044.8513660.27%
2024/02/27245.0300.0045.0023730.54%
2024/02/26144.7500.0045.8013790.26%
2024/02/23445.1000.0044.9543941.01%
2024/02/22345.5500.0045.2533980.75%
2024/02/21345.6500.0045.8034060.74%
2024/02/201046.5300.0045.70104112.43%
2024/02/1500.00646.6046.00-6436-1.38%
2024/01/09348.63148.5548.2521,3250.15%
2023/12/26152.0000.0051.8011,3030.08%
2023/12/11654.8300.0054.1061,2660.47%
2023/12/0700.00453.8553.60-41,258-0.32%
2023/12/0600.00154.6054.60-11,250-0.08%
2023/12/04559.8400.0060.7051,1970.42%
2023/12/0100.00256.3055.30-21,137-0.18%
2023/11/06259.0000.0057.4028610.23%
2023/11/014661.074660.4060.4006900.00%
2023/10/3100.00358.6058.80-3506-0.59%
2023/10/3000.00156.0054.50-1369-0.27%
2023/10/2300.00346.8846.45-3149-2.01%
2023/10/20344.4800.0044.3031382.16%
2023/08/08142.8000.0042.5511260.79%
2023/07/1300.00148.5547.80-1125-0.80%
2023/05/16148.9000.0049.3011590.63%
2023/05/12448.6400.0049.1541672.38%
2023/04/261048.7800.0048.75101845.43%
2023/04/18154.6000.0054.5011800.55%
2023/03/16156.8000.0056.7013240.31%
2023/03/1400.00157.3057.30-1399-0.25%
2023/03/1000.00258.0058.00-2416-0.48%
2023/03/0300.00561.2061.00-5427-1.17%
2023/03/0100.001058.5758.60-10427-2.34%
2023/02/2100.00157.7057.70-1479-0.21%
2023/02/20557.7000.0057.7054921.02%
2023/02/17557.8000.0058.1054961.01%
2023/02/15158.9000.0058.0015100.20%
2023/02/1300.001561.0460.70-15510-2.94%
2023/02/09560.9000.0059.9055200.96%
2023/02/0800.00561.3060.90-5533-0.94%
2023/02/06161.0000.0060.9015730.17%
2023/02/02161.3000.0062.0015760.17%
2023/01/3100.00560.0660.40-5576-0.87%
2023/01/1700.00157.5058.10-1579-0.17%
2023/01/1600.00657.9057.30-6583-1.03%
2023/01/0400.00157.1057.20-1593-0.17%
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音